Literature DB >> 14703574

Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.

Peng Jin1, Daniela C Zarnescu, Stephanie Ceman, Mika Nakamoto, Julie Mowrey, Thomas A Jongens, David L Nelson, Kevin Moses, Stephen T Warren.   

Abstract

Fragile X syndrome is caused by a loss of expression of the fragile X mental retardation protein (FMRP). FMRP is a selective RNA-binding protein which forms a messenger ribonucleoprotein (mRNP) complex that associates with polyribosomes. Recently, mRNA ligands associated with FMRP have been identified. However, the mechanism by which FMRP regulates the translation of its mRNA ligands remains unclear. MicroRNAs are small noncoding RNAs involved in translational control. Here we show that in vivo mammalian FMRP interacts with microRNAs and the components of the microRNA pathways including Dicer and the mammalian ortholog of Argonaute 1 (AGO1). Using two different Drosophila melanogaster models, we show that AGO1 is critical for FMRP function in neural development and synaptogenesis. Our results suggest that FMRP may regulate neuronal translation via microRNAs and links microRNAs with human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14703574     DOI: 10.1038/nn1174

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  246 in total

Review 1.  Local RNA translation at the synapse and in disease.

Authors:  Liqun Liu-Yesucevitz; Gary J Bassell; Aaron D Gitler; Anne C Hart; Eric Klann; Joel D Richter; Stephen T Warren; Benjamin Wolozin
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

Review 3.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

4.  Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis.

Authors:  Ramesh S Pillai; Caroline G Artus; Witold Filipowicz
Journal:  RNA       Date:  2004-08-30       Impact factor: 4.942

Review 5.  Functions of noncoding RNAs in neural development and neurological diseases.

Authors:  Shan Bian; Tao Sun
Journal:  Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.590

6.  MicroRNA-338 regulates the axonal expression of multiple nuclear-encoded mitochondrial mRNAs encoding subunits of the oxidative phosphorylation machinery.

Authors:  Armaz Aschrafi; Amar N Kar; Orlangie Natera-Naranjo; Margaret A MacGibeny; Anthony E Gioio; Barry B Kaplan
Journal:  Cell Mol Life Sci       Date:  2012-07-08       Impact factor: 9.261

Review 7.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 8.  Small RNA-mediated gene regulation in neurodevelopmental disorders.

Authors:  Abrar Qurashi; Peng Jin
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

Review 9.  Understanding neuronal connectivity through the post-transcriptional toolkit.

Authors:  Carlos M Loya; David Van Vactor; Tudor A Fulga
Journal:  Genes Dev       Date:  2010-04-01       Impact factor: 11.361

10.  The conserved P body component HPat/Pat1 negatively regulates synaptic terminal growth at the larval Drosophila neuromuscular junction.

Authors:  Sarala J Pradhan; Katherine R Nesler; Sarah F Rosen; Yasuko Kato; Akira Nakamura; Mani Ramaswami; Scott A Barbee
Journal:  J Cell Sci       Date:  2012-10-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.